Literature DB >> 90105

Characterization of in vitro proliferative responses of human lymphocytes to leishmanial antigens.

D J Wyler, F I Weinbaum, H R Herrod.   

Abstract

Leishmaniasis is an intracellular protozoal infection for which host defense is believed to depend on cellular immune mechanisms. The in vitro proliferative responses of lymphocytes from patients with leishmaniasis and from control subjects to leishmanial antigens were examined. Only lymphocytes from patients responded to 1 microgram of leishmanial antigen/ml, whereas both patient and control lymphocytes responded to 10 micrograms/ml. The nonspecific responses were most likely not due to a mitogenic component in the antigen preparation because cord blood lymphocytes failed to respond at all concentrations of antigen tested. Both specific and nonspecific responses to leishmanial antigens were elicited in purified populations of thymus-derived (T) cells. This lymphocyte proliferation assay can be applied to the assessment of antigen-specific responsiveness of T cells from patients who represent the spectrum of host defense against leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 90105     DOI: 10.1093/infdis/140.2.215

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Characterization of protective T cells in the acquired response to Leishmania donovani in genetically determined cure (H-2b) and noncure (H-2d) mouse strains.

Authors:  O M Ulczak; E Ghadirian; E Skamene; J M Blackwell; P A Kongshavn
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

2.  Immunoregulation of genetically controlled acquired responses to Leishmania donovani infection in mice: demonstration and characterization of suppressor T cells in noncure mice.

Authors:  J M Blackwell; O M Ulczak
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

3.  Suppression of T-lymphocyte responses to Entamoeba histolytica antigen by immune sera.

Authors:  R A Salata; A Martinez-Palomo; L Canales; H W Murray; N Trevino; J I Ravdin
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

4.  Mechanisms associated with immunoregulation in human American cutaneous leishmaniasis.

Authors:  M Castés; A Agnelli; A J Rondón
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

5.  Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis.

Authors:  J P Haldar; S Ghose; K C Saha; A C Ghose
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

6.  Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis.

Authors:  M Kemp; J A Kurtzhals; K Bendtzen; L K Poulsen; M B Hansen; D K Koech; A Kharazmi; T G Theander
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

7.  Immunosuppression in Kenyan visceral leishmaniasis.

Authors:  M Ho; D K Koech; D W Iha; A D Bryceson
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

8.  The Indian langur: preliminary report of a new nonhuman primate host for visceral leishmaniasis.

Authors:  R Pal; K Zehra; J C Katiyar; N Sethi; G Bhatia; R K Singh
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

9.  Efficacy of Leishmania donovani trypanothione reductase, identified as a potent Th1 stimulatory protein, for its immunogenicity and prophylactic potential against experimental visceral leishmaniasis.

Authors:  Prashant Khare; Anil Kumar Jaiswal; Chandra Dev Pati Tripathi; Sumit Joshi; Shyam Sundar; Anuradha Dube
Journal:  Parasitol Res       Date:  2013-12-27       Impact factor: 2.289

10.  T-cell responses to infected autologous monocytes in patients with cutaneous and mucocutaneous leishmaniasis.

Authors:  A M Cooper; P C Melby; C L Karp; F Neva; D L Sacks
Journal:  Clin Diagn Lab Immunol       Date:  1994-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.